BRN Discussion Ongoing
- Thread starter TechGirl
- Start date
Vladsblood
Regular
Itās in the secret
sauce of Peter Van Der Madgeās making. Thatās the connection
HopalongPetrovski
I'm Spartacus!
We talkin' dick pic's, or, just what did you have in mind?Yes, it really would be appreciated
I noticed PainChek was listed as a partner on the Nviso page. It was on a page seemingly dedicated to Brainchip technology. What a great use of Akida , if indeed it is Akida, especially for the elderly who canāt communicate
The first PainChekĀ® clinical pain assessment in aged care was at Barossa Village in South Australia. Three years on, PainChekĀ® has now established itself as the new standard in pain assessment and has expanded across the whole of Australia and around the globe.
PainChekĀ® Universal is a medical device and has regulatory clearance in Australia, UK, European Union, Canada, Singapore and New Zealand.
PainChekĀ® is now licensed in over 1,500 aged care facilities covering four regions of the world and more than 850,000 cumulative pain assessments have been conducted to date1. This has enabled better pain management for people who cannot reliably verbalise their pain ā particularly those living with dementia and cognitive impairment.
The PainChekĀ® Universal solution enables better pain management by:
PainChekĀ® is a fully digital healthcare solution and can be operated from up to 3m away from the person being assessed. This aligns with social distancing requirements, minimising infection risks during both the current COVID-19 crisis, and any future viral outbreaks which may impact the vulnerable.
Finally, PainChekĀ® Universal helps to keep all your processes aligned as it integrates directly into Care Management Systems. Pain data is safely stored in one place from which powerful real-time reporting via PainChekĀ® Analytics supports your critical clinical decision-making.
www.painchek.com
www.nviso.ai
The first PainChekĀ® clinical pain assessment in aged care was at Barossa Village in South Australia. Three years on, PainChekĀ® has now established itself as the new standard in pain assessment and has expanded across the whole of Australia and around the globe.
PainChekĀ® Universal is a medical device and has regulatory clearance in Australia, UK, European Union, Canada, Singapore and New Zealand.
PainChekĀ® is now licensed in over 1,500 aged care facilities covering four regions of the world and more than 850,000 cumulative pain assessments have been conducted to date1. This has enabled better pain management for people who cannot reliably verbalise their pain ā particularly those living with dementia and cognitive impairment.
Introducing the Universal Pain Assessment Solution
As part of the next step in the evolution of pain assessment, PainChekĀ® continues to innovate with the Universal Pain Assessment Solution ā enabling best practice pain management for all people, everywhere.The PainChekĀ® Universal solution enables better pain management by:
- Giving a voice to those who cannot reliably verbalise their pain, through a unique AI driven assessment tool
- Document the pain for those who can self-report, and
- Providing the right pain assessment solution for those whose ability to communicate fluctuates
PainChekĀ® is a fully digital healthcare solution and can be operated from up to 3m away from the person being assessed. This aligns with social distancing requirements, minimising infection risks during both the current COVID-19 crisis, and any future viral outbreaks which may impact the vulnerable.
Finally, PainChekĀ® Universal helps to keep all your processes aligned as it integrates directly into Care Management Systems. Pain data is safely stored in one place from which powerful real-time reporting via PainChekĀ® Analytics supports your critical clinical decision-making.
The Gold Standard of Pain Assessment Tools in Aged Care
Over 990 aged care facilities use PainChek's pain assessment tools for aged care to detect pain in residents, with 350,000 assessments completed to date.
www.painchek.com
Neuromorphic Computing - NVISO
HUMAN BEHAVIOUR AI NEUROMORPHIC COMPUTING NVISO empowers system integrators to build AI-driven human machine interfaces to transform our lives using neuromorphic computing. Understand people and their behavior in real-time without an internet connection to make autonomous devices safe, secure...
www.nviso.ai
Dhm
Regular
https://cdn-api.markitdigital.com/a...access_token=83ff96335c2d45a094df02a206a39ff4
What do we make of this? Certainly a justified reason.Only 125k shares out of a whole lot more.
What do we make of this? Certainly a justified reason.Only 125k shares out of a whole lot more.
wilzy123
Founding Member
One would be obliged to believe that it was an "On Market Sale for the purpose of meeting taxation obligation as a result of previous vesting of RSUs". If it were for any other reason than stipulated, then this would be unlawful?
And also that the ANN is ..............
Last edited:
Tony Coles
Regular
chapman89
Founding Member
This is interesting although Iām not surprised.
A person by the name of Manish Pandey who works for Synopsys as Fellow, Vice President of R&D is also a adjunct professor at Carnegie Mellon University with Machine Learning, Systems and Computer Architecture.
Now we know that Brainchip has the āBrainChip University AI Accelerator Program which shares technical knowledge, promotes leading-edge discoveries and positions students to be next-generation technology innovatorsā
We also know that Synopsys is offering us in their Data Centre AI thanks to the Synopsys investor presentation back a few months ago, well itās suspected they are as they were using a photo of Brainchip accelerator, which is hard to find even if you Google it, not to mention itās a copyright issue if they werenāt working together and Synopsys has taken it upon themselves to just use somebody elseās photo of a product thatās not theirs.
Is this a coincidence? I think not.
A person by the name of Manish Pandey who works for Synopsys as Fellow, Vice President of R&D is also a adjunct professor at Carnegie Mellon University with Machine Learning, Systems and Computer Architecture.
Now we know that Brainchip has the āBrainChip University AI Accelerator Program which shares technical knowledge, promotes leading-edge discoveries and positions students to be next-generation technology innovatorsā
We also know that Synopsys is offering us in their Data Centre AI thanks to the Synopsys investor presentation back a few months ago, well itās suspected they are as they were using a photo of Brainchip accelerator, which is hard to find even if you Google it, not to mention itās a copyright issue if they werenāt working together and Synopsys has taken it upon themselves to just use somebody elseās photo of a product thatās not theirs.
Is this a coincidence? I think not.
Last edited:
Dhm
Regular
Heās chairmanHis in retirement as everybody knows and maybethe Mrs wanted a new kitchen! Or suffer the consequences of continuous headaches from the non stop
yapping.
Sirod69
bavarian girl ;-)
The idea of #neuromorphic computing has now really caught up and we want to see how far we can go in this path. Let me invite you to the TCS Forum: Thought Leadership Conversations organised by Tata Consultancy Services on this topic - "Neuromorphic Computing for Transformation of the Industrial Future" where leaders from the academia and industry will take us on an enthralling journey through this evolving concept.
Our distinguished guests are Dr Mary Doborje, Dr. Zohreh Doborjeh, Dr. Priyadarshini Panda, Dr. Manan Suri, Anupam Singhal, Dr. Arpan Pal, and Vincent Ofrecio.
Ple
ase join us on 16th November to get a glimpse of the future. The registration link is - https://lnkd.in/gueZGy6u
Our distinguished guests are Dr Mary Doborje, Dr. Zohreh Doborjeh, Dr. Priyadarshini Panda, Dr. Manan Suri, Anupam Singhal, Dr. Arpan Pal, and Vincent Ofrecio.
Ple
HopalongPetrovski
I'm Spartacus!
Well, we were talking about sharing a sofa
Sirod69
bavarian girl ;-)
there is space for severalWell, we were talking about sharing a sofa
Fact Finder
Top 20
Hi again @Dhm
I am glad you asked this question as I was just discussing this privately with @stan9614.
It is VERY important to remember what has gone before in Annual Reports and presentations to shareholders and for newer shareholders to go back and read these documents.
Brainchip advised shareholders that to be commercially successful they needed to employ the best people.
Brainchip advised shareholders that it did not have the cash to offer attractive salaries to entice the best people so it could only get the best people by offering a salary made up of cash and shares.
So todays announcement of the sale of 125,000 shares to pay tax is as significant as your employer paying you your salary and handing you a payslip on which all the deductions are noted one of which being the tax paid out of the companies cash reserves to the Australian Taxation Office on your behalf.
In other words in my opinion as these shares are part of his agreed salary the sale of 125,000 to pay tax on his salary is a non event and of no significance whatsoever.
My opinion only DYOR
FF
AKIDA BALLISTA
Wow that's scathing of BRN and without the benefit of the research here it would create some serious doubts in my mind - particularly while wallowing in a sea of red. No wonder the average punter is running for the exits.I want to keep these ramblings for the next 2-3 years and resend them to MF. I used to get upset by them and worry. Now I just smile and consider the repetitive nature of the comments and go about my day.
5 reasons I would avoid BrainChip shares at all costs
Here's why I think ASX semiconductor company Brainchip Holdings Ltd (ASX: BRN) shares should be avoided by investors at all costs.www.fool.com.au
It's funny tho isn't it - the peanut reporting gleefully uses the highest ever price compared to today's price as an example if how much money you would have lost if you bought into BRN..... at the highest price. But he then says he's been following BRN for years. Does this not then mean he's actually missed out on a huge 10X or better return had he bought way back then. Had he told his subscribers to purchase at 5c I'm sure they'd all be pretty damn happy. The Motley F'wits convolute the dialogue to suit their own purposes. I'm sick of hearing them say we don't stand a chance because the behemoth companies spend more on R&D. They site lack of news is directly related to lack of progress without a single mention of NDA's - this is poor and manipulative information. Unfortunately, despite all of the holes, the MF's theory will hold water, albeit dirty, until revenue outpaces expenses. We need that revenue to shut these people up.
Fact Finder
Top 20
Hi @Foxdog
I love your post and agree with it right up until you suggest that income outpacing expense will shut up MF types.
They do not care for the truthful balanced reporting of properly researched FACTS.
Once income is outpacing expense they will make a U turn and head up the ramp onto the PE ratio highway stating that after years and years of trying to become a commercially successful technology company their PE is āXā and shareholders dreams of promised dividends have been dashed.
They have agendaās that are not served by the truth and never will be.
If their statements align with the truth or known facts it is but a coincidence.
My opinion only DYOR
FF
AKIDA BALLISTA
HopalongPetrovski
I'm Spartacus!
You'll never shut these fools up.
Even if they fell into a convenient black hole another group of hyena's would spring up to take their place.
Their business model works, regardless of the morality of the situation.
As PT apparently said........... "There's one born every minute"
Dr E Brown
Regular
The other thing to note is that the company he proposes would be a better investment than Brainchip is down over 50% from its high price this year. Also he holds the company he proposes as do others in MF. Well knock me down with a feather duster!
Tzatziki?Itās in the secret
Similar threads
